Inventor
LIVINGSTON DAVID J
US41 patents
⚠️ This page may combine multiple inventors who share the name “LIVINGSTON DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
24 patentsUS5716929AFeb 10, 1998
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA137 citations99
US5656627AAug 12, 1997
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA146 citations99
US5973111AOct 26, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA91 citations98
US5874424AFeb 23, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA141 citations98
US5847135ADec 8, 1998
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA159 citations98
US6350741B1Feb 26, 2002
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA112 citations97
US6423840B1Jul 23, 2002
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA40 citations96
US6420522B1Jul 16, 2002
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA72 citations96
US6258948B1Jul 10, 2001
Inhibitors of Interleukin-1β converting enzyme
VERTEX PHARMA42 citations96
US6204261B1Mar 20, 2001
Inhibitors of interleukin-1β Converting enzyme inhibitors
VERTEX PHARMA80 citations96
US6103711AAug 15, 2000
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA80 citations96
US5985863ANov 16, 1999
Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
VERTEX PHARMA64 citations96
US5843904ADec 1, 1998
Inhibitors of interleukin-1βconverting enzyme
VERTEX PHARMA51 citations96
US7288624B2Oct 30, 2007
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA48 citations94
US5856116AJan 5, 1999
Crystal structure and mutants of interleukin-1 beta converting enzyme
VERTEX PHARMA43 citations94
US7790713B2Sep 7, 2010
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA24 citations92
US6162790ADec 19, 2000
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA17 citations92
US6008217ADec 28, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA37 citations92
US7772366B2Aug 10, 2010
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA24 citations91
US6974809B2Dec 13, 2005
Inhibitors of interleukin 1-β converting enzyme
VERTEX PHARMA5 citations74
US6329365B1Dec 11, 2001
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA5 citations74
US6057119AMay 2, 2000
Crystal structure and mutants of interleukin-1β converting enzyme
VERTEX PHARMA10 citations72
US5763590AJun 9, 1998
Isolation of an Mr 52,000 FK506 binding protein and molecular cloning of a corresponding human cDNA
VERTEX PHARMA10 citations68
US6573259B2Jun 3, 2003
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA3 citations63
METRO INT BIOTECH LLC
14 patentsUS10233208B1Mar 19, 2019
Crystal forms of beta-nicotinamide mononucleotide
METRO INT BIOTECH LLC14 citations94
US10548913B2Feb 4, 2020
Nicotinamide mononucleotide derivatives and their uses
METRO INT BIOTECH LLC18 citations93
US10392415B2Aug 27, 2019
Crystal forms of β-nicotinamide mononucleotide
METRO INT BIOTECH LLC10 citations92
US10392416B2Aug 27, 2019
Crystal forms of beta-nicotinamide mononucleotide
METRO INT BIOTECH LLC10 citations92
US9855289B2Jan 2, 2018
Nicotinamide mononucleotide derivatives and their uses
METRO INT BIOTECH LLC19 citations92
US9919003B2Mar 20, 2018
Nicotinamide mononucleotide derivatives and their uses
METRO INT BIOTECH LLC16 citations91
US11059847B2Jul 13, 2021
Crystal forms of β-nicotinamide mononucleotide
METRO INT BIOTECH LLC9 citations85
US11464796B2Oct 11, 2022
Nicotinamide mononucleotide derivatives and their uses
METRO INT BIOTECH LLC6 citations84
US11878027B2Jan 23, 2024
Nicotinamide mononucleotide derivatives and their uses
METRO INT BIOTECH LLC2 citations72
US12391721B2Aug 19, 2025
Crystal forms of beta-nicotinamide mononucleotide
METRO INT BIOTECH LLC0 citations62
US12485135B2Dec 2, 2025
Nicotinamide mononucleotide derivatives and their uses
METRO INT BIOTECH LLC0 citations61
US12516081B2Jan 6, 2026
Anti-viral compounds and methods of use
METRO INT BIOTECH LLC0 citations60
US11279727B2Mar 22, 2022
Anti-viral compounds and methods of use
METRO INT BIOTECH LLC1 citations60
US11878994B1Jan 23, 2024
Compositions for treatment of inflammation
METRO INT BIOTECH LLC0 citations59
HOECHST MARION ROUSSEL INC
2 patentsUS6020477AFeb 1, 2000
DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme
HOECHST MARION ROUSSEL INC2 citations56
US6180386B1Jan 30, 2001
DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzyme
HOECHST MARION ROUSSEL INC0 citations46